A detailed history of Czech National Bank transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Czech National Bank holds 358,018 shares of BMY stock, worth $14.3 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
358,018
Previous 356,435 0.44%
Holding current value
$14.3 Million
Previous $18.3 Million 6.16%
% of portfolio
0.25%
Previous 0.26%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 10, 2024

BUY
$47.98 - $54.4 $75,952 - $86,115
1,583 Added 0.44%
358,018 $19.4 Million
Q4 2023

Jan 08, 2024

SELL
$48.48 - $57.85 $422,406 - $504,047
-8,713 Reduced 2.39%
356,435 $18.3 Million
Q3 2023

Oct 19, 2023

BUY
$57.89 - $64.73 $6.74 Million - $7.54 Million
116,449 Added 46.82%
365,148 $21.2 Million
Q2 2023

Jul 11, 2023

SELL
$63.71 - $70.74 $113,021 - $125,492
-1,774 Reduced 0.71%
248,699 $15.9 Million
Q1 2023

Apr 17, 2023

BUY
$65.71 - $74.53 $99,879 - $113,285
1,520 Added 0.61%
250,473 $17.4 Million
Q4 2022

Jan 18, 2023

BUY
$68.48 - $81.09 $50,812 - $60,168
742 Added 0.3%
248,953 $0
Q3 2022

Oct 31, 2022

BUY
$0.13 - $76.84 $32,267 - $19.1 Million
248,211 New
248,211 $17.6 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $85B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Czech National Bank Portfolio

Follow Czech National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Czech National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Czech National Bank with notifications on news.